|
Volumn 21, Issue 12, 2006, Pages 1090-1092
|
Oral baclofen and clonidine for treatment of spacticity in children
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BACLOFEN;
BENZODIAZEPINE DERIVATIVE;
CARBIDOPA PLUS LEVODOPA;
CLONIDINE;
SPASMOLYTIC AGENT;
TIZANIDINE;
ADOLESCENT;
ADULT;
AGE;
ARTICLE;
BRAIN INJURY;
CEREBRAL PALSY;
CHILD;
COMORBIDITY;
CORRELATION ANALYSIS;
DISEASE DURATION;
DOSE CALCULATION;
FEMALE;
HUMAN;
HYPOTENSION;
INFANT;
LETHARGY;
MAJOR CLINICAL STUDY;
MALE;
MAXIMUM PERMISSIBLE DOSE;
MEDICAL RECORD REVIEW;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SEDATION;
SEIZURE;
SIDE EFFECT;
SPASTICITY;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADRENERGIC ALPHA-AGONISTS;
ADULT;
AGE FACTORS;
BACLOFEN;
BRAIN INJURIES;
CENTRAL NERVOUS SYSTEM;
CEREBRAL PALSY;
CHILD;
CHILD, PRESCHOOL;
CLONIDINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG SYNERGISM;
DRUG THERAPY, COMBINATION;
FEMALE;
GABA AGONISTS;
HUMANS;
INFANT;
MALE;
MUSCLE SPASTICITY;
MUSCLE, SKELETAL;
RETROSPECTIVE STUDIES;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 33846359225
PISSN: 08830738
EISSN: None
Source Type: Journal
DOI: 10.1177/7010.2006.00134 Document Type: Article |
Times cited : (29)
|
References (12)
|